Effects of reduced glutathione combined with high-flux hemodialysis on serum CysC, KIM-1 and Scr in patients with acute kidney injury
Empathetic and Compassionate Care: Our brand is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized
2023;30:e220344
The Relapse Reality: Weight Regain After Stopping GLP-1 Therapy A landmark 2022 clinical trial found that participants who discontinued tirzepatide after achieving weight loss regained an average of 60% of their lost weight over 12 months
The most precise advice will come from your healthcare provider, who can provide a personalised recommendation based on the specific antibiotic and your individual health profile
Tell us about your weight history, BMI, related conditions, prior GLP-1 use, and goals